跳至主要内容
临床试验/NCT06089694
NCT06089694已完成不适用

Crome/Cobalt Respiration Study

Medtronic Cardiac Rhythm and Heart Failure6 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2023年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
61
试验地点
6
主要终点
Respiration Rates Comparison (Activities Representative of Nightly Average)

研究概览

简要总结

The goal of this study is to compare measured respiration rates in various subject scenarios and use conditions between capnography and the Crome and Cobalt ICD and CRT-D MRI SureScan devices (derived using a Holter recorder).

详细描述

This study will enroll subjects who have already received a Medtronic Crome or Cobalt ICD or CRT-D MRI SureScan device and who meet all of the inclusion criteria and none of the exclusion criteria. Subjects will be asked to complete various breathing/exercise activities while connected to a capnography monitor and a Holter recorder and respiration rates from both devices will be compared for accuracy, with the capnography monitor being the source of truth.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has an active CromeTM or CobaltTM ICD or CRT-D MRI SureScanTM system which has been implanted for at least 30 days and which has not yet reached the Recommended Replacement Time (RRT)
  • Subject is implanted with one of the following models of a true bipolar right ventricular lead manufactured by Medtronic:
  • Model 6946M
  • Model 6947
  • Model 6947M
  • Model 6935
  • Model 6935M
  • Subject is ≥ 18 years of age
  • Subject (or subject's legally authorized representative) is willing and able to provide written informed consent
  • Subject is willing and able to comply with study procedures

排除标准

  • Subject has existing condition that necessitates the use of supplemental oxygen
  • Subject has active acute respiratory infection or respiratory disorder that may affect ability to perform breathing or exercise activities, as assessed by the investigator
  • Any concomitant condition that might endanger the subject through participation in the study or interfere with study procedures, as assessed by the investigator
  • Subject has an active or suspected lead integrity issue, in the opinion of the investigator
  • Subject is enrolled in another study that could confound the results of this study
  • Subject has NYHA Class IV heart failure

结局指标

主要结局

Respiration Rates Comparison (Activities Representative of Nightly Average)

时间窗: During In-clinic Testing Visit, an average of 2 hours

Difference between the daily respiration rate determined using capnography and the daily respiration rate determined by the Crome and Cobalt ICD and CRT-D devices.

Daily Capnography Respiration Rate

时间窗: During In-clinic Testing Visit, an average of 2 hours

Daily respiration rates will be calculated using a series of paired device-derived respiration rates and capnography waveform-derived respiration rates, where the capnography respiration rate will be the source of truth. The differences in these daily respiration rates will be evaluated to determine whether the daily device-derived respiration rate accuracy is acceptable (i.e., consistently within +/- 3 breaths per minute of the true respiration rate).

Daily Device-derived Respiration Rate

时间窗: During In-clinic Testing Visit, an average of 2 hours

Daily respiration rate determined by the Crome and Cobalt ICD and CRT-D devices.

Difference in Respiration Rate

时间窗: During In-clinic Testing Visit, an average of 2 hours

Difference between the daily respiration rate determined using capnography and the daily respiration rate determined by the Crome and Cobalt ICD and CRT-D devices.

次要结局

未报告次要终点

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验